Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2023-04-06 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
安信证券股份有限公司关于盈康生命科技股份有限公司2022年度定期现场检查报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2022年度定期现场检查报告" which translates to "2022 Annual Periodic On-site Inspection Report" by a securities company (安信证券股份有限公司) regarding 盈康生命科技股份有限公司. The content includes detailed governance, internal control, information disclosure, protection of company interests, use of raised funds, performance, and shareholder commitments. It is a comprehensive inspection report covering the company's governance and compliance for the year 2022. It is not a full annual report (10-K), nor an audit report (AR) in the traditional sense, but rather a regulatory on-site inspection report by the sponsor institution. This type of document fits best under the category of Audit Report / Information (AR) as it is a standalone inspection report related to regulatory compliance and internal controls, not a full annual report or other categories. The document length is sufficient and contains substantive content, not just an announcement or certification. Therefore, the classification is AR with high confidence. FY 2022
2023-04-06 Chinese
关于召开2022年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2022 Annual General Meeting (AGM) of 盈康生命科技股份有限公司, including the date, time, location, agenda items, voting procedures, and proxy forms. It does not contain the actual annual report or financial statements but rather the announcement and information related to the AGM itself. The document length is about 5039 characters, which is consistent with a detailed AGM notice. Therefore, this document fits the category of AGM Information (AGM-R).
2023-03-29 Chinese
独立董事关于第五届董事会第三十一次会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding the pre-approval of the reappointment of an audit firm for the company's 2023 audit. It references regulatory rules and the company's articles of association, and it is a short document (692 characters) focused on governance and audit firm appointment. It does not contain financial statements or detailed audit results, nor is it a full audit report or annual report. It is a governance-related document concerning board approval and audit firm engagement. Therefore, it fits best under Board/Management Information (MANG), which covers announcements related to board decisions and management matters such as audit firm appointments.
2023-03-29 Chinese
独立董事关于第五届董事会第三十一次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion report from the independent directors of 盈康生命科技股份有限公司 regarding various matters discussed at the 31st meeting of the 5th board of directors. It covers internal control self-evaluation, use of raised funds, profit distribution, appointment of auditors, remuneration for directors and senior management, project delays, termination of a stock incentive plan, and related party transactions. The document is not a full annual report or audit report but an independent directors' statement on board meeting matters, which is typically part of board/management information disclosures. It does not contain financial statements or earnings highlights, nor is it a regulatory announcement or proxy material. Therefore, the best fitting category is Board/Management Information (MANG). The document length is 3093 characters, which is relatively short but contains substantive independent opinions on board matters, not just an announcement or certification.
2023-03-29 Chinese
安信证券股份有限公司关于盈康生命科技股份有限公司部分募集资金投资项目延期的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from a sponsoring securities company (安信证券股份有限公司) regarding the delay in certain investment projects funded by raised capital for 盈康生命科技股份有限公司. It includes specifics about the capital raised, project investment amounts, reasons for delays, and approvals from the board, independent directors, and supervisory board. The document references regulatory compliance and internal approvals but does not present financial statements or earnings data. It is a formal verification and opinion report on the delay of capital investment projects, which aligns with an Audit Report / Information (AR) type, as it involves verification and regulatory compliance related to capital use but is not a full annual or interim financial report. The document length is under 5,000 characters, but it contains substantive content and is not merely an announcement or certification letter, so it is not RPA or RNS. Therefore, the best fit is AR (Audit Report / Information). FY 2022
2023-03-29 Chinese
上海荣正企业咨询服务（集团）股份有限公司关于盈康生命科技股份有限公司终止实施2022年限制性股票激励计划事项之独立财务顾问报告
Board/Management Information Classification · 95% confidence The document is an independent financial advisor report regarding the termination of the 2022 restricted stock incentive plan of Yingkang Life Technology Co., Ltd. It includes detailed explanations, legal and regulatory references, approval processes, and the advisor's conclusion on the fairness and compliance of the termination. The document is not a general annual report, earnings release, or a simple announcement but a specialized advisory report related to a corporate governance and compensation matter. It is not a proxy solicitation or voting result announcement but a detailed advisory report on a management-related decision. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes or decisions involving senior management and board-related matters such as stock incentive plans.
2023-03-29 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.